2,494 results on '"Solomon Daniel H"'
Search Results
202. Classifying Pseudogout Using Machine Learning Approaches With Electronic Health Record Data
203. Treat‐to‐Target Approach in Rheumatoid Arthritis: A Quality Improvement Trial
204. Validation of claims-based algorithms for identification of high-grade cervical dysplasia and cervical cancer
205. Rates of Bone Loss Among Women Initiating Antidepressant Medication Use in Midlife
206. Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonist
207. Effects of Xanthine Oxidase Inhibitors on Cardiovascular Disease in Patients with Gout: A Cohort Study
208. Risk of Venous Thromboembolism in Patients with Rheumatoid Arthritis: Initiating Disease-Modifying Antirheumatic Drugs
209. Improving Care of Patients At-Risk for Osteoporosis: A Randomized Controlled Trial
210. Incidental vertebral fractures on chest radiographs: Recognition, documentation, and treatment
211. Veteran's affairs hospital discharge databases coded serious bacterial infections accurately
212. Patterns of bone mineral density testing: Current guidelines, testing rates, and interventions
213. Risk of death in elderly users of conventional vs. atypical antipsychotic medications
214. User experience with a voice-enabled smartphone app to collect patient-reported outcomes in rheumatoid arthritis
215. Adverse effects related to methotrexate polyglutamate levels: adjudicated results from the cardiovascular inflammation reduction trial
216. Adverse Effects of Low‐Dose Methotrexate in a Randomized Double‐Blind Placebo‐Controlled Trial: Adjudicated Hematologic and Skin Cancer Outcomes in the Cardiovascular Inflammation Reduction Trial
217. Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors
218. Assessing the Need for Improved Access to Rheumatology Care: A Survey of Massachusetts Community Health Center Medical Directors
219. A Patient with Migrating Polyarthralgias
220. Unresolved Questions in Rheumatology: Motion for Debate: The Data Support Evidence-Based Management Recommendations for Cardiovascular Disease in Rheumatoid Arthritis
221. Incidence and predictors of secondary fibromyalgia in an early arthritis cohort
222. Surgery versus Physical Therapy for a Meniscal Tear and Osteoarthritis
223. Association between anti-TNF-α therapy and interstitial lung disease
224. Republished: A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritis
225. Association Between the Initiation of Anti–Tumor Necrosis Factor Therapy and the Risk of Herpes Zoster
226. Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000–2004
227. Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis
228. The Role of Sleep Problems in Central Pain Processing in Rheumatoid Arthritis
229. Tumor Necrosis Factor α Inhibitor Therapy and Cancer Risk in Chronic Immune-Mediated Diseases
230. Increasing Pneumococcal Vaccination for Immunosuppressed Patients: A Cluster Quality Improvement Trial
231. A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritis
232. Managing fractures and osteoporosis in patients with RA: focusing on a comorbid condition and its increased morbidity and mortality
233. Association between anti-TNF-α therapy and all-cause mortality
234. If life serves up a bowl of cherries, and gout attacks are “the pits”: Implications for therapy
235. Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis
236. Implementing a Treat‐to‐Target Approach for Rheumatoid Arthritis During the COVID‐19 Pandemic: Results of a Virtual Learning Collaborative Program.
237. The relationship between 19‐year trends in medication use and changes in physical function among women in the mid‐life: A Study of Women's Health Across the Nation pharmacoepidemiology study.
238. Explained variation in a model of therapeutic decision making is partitioned across patient, physician, and clinic factors
239. Pharmacoeconomic Aspects of Rheumatoid Arthritis Management
240. Contributors
241. No differences in cancer screening rates in patients with rheumatoid arthritis compared to the general population
242. Does Motivational Interviewing Improve Medication Adherence?—Reply
243. Are we content that risk of cancer is not appreciably increased after tumor necrosis factor inhibitor use? Comment on the article by Solomon et al
244. New loop diuretic prescriptions may be an acute risk factor for falls in the nursing home
245. Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort
246. Rates of malignancy associated with juvenile idiopathic arthritis and its treatment
247. Osteoporosis Telephonic Intervention to Improve Medication Regimen Adherence: A Large, Pragmatic, Randomized Controlled Trial
248. Contributors
249. Nonoccupational risk factors for carpal tunnel syndrome
250. Initiation of Tumor Necrosis Factor-α Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.